FDA Inspection
Laboratoires ClarinsLaboratoires Clarins – FDA Inspection, Oct 14, 2022
Record Details
This FDA Inspection record concerns Laboratoires Clarins, with an inspection on October 14, 2022, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Laboratoires Clarins
- Inspection Date
- October 14, 2022
- Product Type
- Drugs
View Company Profile
ID · 95dfbe98-f5e7-4d21-a05b-b8ba126f7737
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1181478
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
3- 21 CFR 211.68(b)Computer control of master formula records
- 21 CFR 211.165(e)Test methods
- 21 CFR 211.67(b)Written procedures fail to include
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Laboratoires Clarins
2| Date | Classification | Office | Project area |
|---|---|---|---|
| September 21, 2018 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 21, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Laboratoires Clarins
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.